NCT02147808View on ClinicalTrials.gov

A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Conditions
Drug Interactions
Interventions
DRUG

Telotristat etiprate

All subjects will receive two 250 mg telotristat etiprate tablets three times daily.

DRUG

Midazolam

All subjects will receive 3 mg (1.5 mL oral syrup \[2mg/mL\]).

Trial Locations (1)

53704

Lexicon Investigational Site, Madison

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY